Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.

Wilson DG, Poole WE, Chauhan SK, Rogers BA.

Bone Joint J. 2016 Aug;98-B(8):1056-61. doi: 10.1302/0301-620X.98B8.36957. Review.

PMID:
27482017
2.

The Effect of Administration Protocol of Subcutaneous Enoxaparin Injection on Formation of Ecchymosis.

Uzun S, Aciksoz S, Arslan F, Yildiz C, Akyol M.

Orthop Nurs. 2016 Mar-Apr;35(2):120-5; quiz 126-7. doi: 10.1097/NOR.0000000000000227.

PMID:
27028689
3.

Thromboprophylaxis after major orthopedic surgery: Improving compliance with clinical practice guidelines.

Bautista M, Llinás A, Bonilla G, Mieth K, Diaz M, Rodriguez F; Clinical Care Program in Joint Replacements.

Thromb Res. 2016 Jan;137:113-8. doi: 10.1016/j.thromres.2015.10.020. Epub 2015 Oct 22.

PMID:
26654717
4.

Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.

Haighton M, Kempen DH, Wolterbeek N, Marting LN, van Dijk M, Veen RM.

J Orthop Surg Res. 2015 Sep 17;10:145. doi: 10.1186/s13018-015-0285-6.

5.

Rivaroxaban versus high dose nadroparin for thromboprophylaxis after hip or knee arthroplasty.

Heckmann M, Thermann H, Heckmann F.

Hamostaseologie. 2015;35(4):358-63. doi: 10.5482/HAMO-14-12-0078. Epub 2015 Jul 21.

PMID:
26194889
6.

Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.

Dixon J, Ahn E, Zhou L, Lim R, Simpson D, Merriman EG.

Intern Med J. 2015 Apr;45(4):416-22. doi: 10.1111/imj.12702.

PMID:
25644232
7.

Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study.

Perez Botero J, Spoon DB, Patnaik MS, Ashrani AA, Trousdale RT, Pruthi RK.

Thromb Res. 2015 Jan;135(1):109-13. doi: 10.1016/j.thromres.2014.11.010. Epub 2014 Nov 18.

PMID:
25434629
8.

High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.

Leijtens B, Kremers van de Hei K, Jansen J, Koëter S.

Arch Orthop Trauma Surg. 2014 Sep;134(9):1335-41. doi: 10.1007/s00402-014-2034-4. Epub 2014 Jul 3.

PMID:
24990654
9.

Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty.

Wang Z, Anderson FA Jr, Ward M, Bhattacharyya T.

PLoS One. 2014 Apr 9;9(4):e91755. doi: 10.1371/journal.pone.0091755. eCollection 2014.

10.

Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.

Bloch BV, Patel V, Best AJ.

Bone Joint J. 2014 Jan;96-B(1):122-6. doi: 10.1302/0301-620X.96B1.31569.

PMID:
24395322
11.

The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.

Yassin M, Mitchell C, Diab M, Senior C.

Int Orthop. 2014 May;38(5):1073-5. doi: 10.1007/s00264-013-2233-6. Epub 2013 Dec 19.

12.

Perioperative antithrombotic management in joint replacement surgeries.

Lee HL, Chiu KY, Yiu KH, Ng FY, Yan CH, Chan PK.

Hong Kong Med J. 2013 Dec;19(6):531-8. doi: 10.12809/hkmj134073. Epub 2013 Oct 21. Review.

13.

Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.

Dahl OE, Gudmundsen TE, Pripp AH, Aanesen JJ.

Clin Appl Thromb Hemost. 2014 Mar;20(2):117-23. doi: 10.1177/1076029613499820. Epub 2013 Oct 10.

PMID:
24113492
14.

Prevention of venous thromboembolic disease after total hip and knee arthroplasty.

Lieberman JR, Pensak MJ.

J Bone Joint Surg Am. 2013 Oct 2;95(19):1801-11. doi: 10.2106/JBJS.L.01328. Review.

PMID:
24088973
15.

Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.

Schousboe JT, Brown GA.

J Bone Joint Surg Am. 2013 Jul 17;95(14):1256-64. doi: 10.2106/JBJS.L.00400.

PMID:
23864173
16.

Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies.

Fuji T, Nakamura M, Takeuchi M.

Clin Appl Thromb Hemost. 2014 Mar;20(2):199-211. doi: 10.1177/1076029612457810. Epub 2012 Sep 4.

PMID:
22952213
17.

Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study.

Mills RM, Berkowitz RD, Damaraju CV, Jennings LK, Wildgoose P.

Thromb Res. 2012 Nov;130(5):709-15. doi: 10.1016/j.thromres.2012.07.014. Epub 2012 Aug 2.

PMID:
22857800
18.

Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.

Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I, Muller SD.

J Bone Joint Surg Am. 2012 Sep 5;94(17):1554-8.

PMID:
22832942
19.

Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.

Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis SG, Gonzalez Della Valle A.

Int Orthop. 2012 Oct;36(10):1995-2002. doi: 10.1007/s00264-012-1588-4. Epub 2012 Jun 12.

20.

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.

Raskob GE, Gallus AS, Pineo GF, Chen D, Ramirez LM, Wright RT, Lassen MR.

J Bone Joint Surg Br. 2012 Feb;94(2):257-64. doi: 10.1302/0301-620X.94B2.27850.

PMID:
22323697

Supplemental Content

Loading ...
Support Center